Selected research
Industry Research
Long-Acting Growth Hormone(LAGH) Industry Research Report 2026
Market perspective
The global Long-Acting Growth Hormone(LAGH) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Long-Acting Growth Hormone(LAGH) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Long-Acting Growth Hormone(LAGH) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Long-Acting Growth Hormone(LAGH) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Long-Acting Growth Hormone(LAGH) include Eli Lilly, GeneScience Pharmaceuticals, Pfizer, Anhui Anke Biotechnology, Sandoz International, Novo Nordisk, Merck Serono, LG Life Sciences and Ipsen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Long-Acting Growth Hormone(LAGH) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Long-Acting Growth Hormone(LAGH) Market by Company
Eli Lilly
GeneScience Pharmaceuticals
Pfizer
Anhui Anke Biotechnology
Sandoz International
Novo Nordisk
Merck Serono
LG Life Sciences
Ipsen
Ferring Pharmaceuticals
F. Hoffmann-La Roche
Long-Acting Growth Hormone(LAGH) Segment by Type
Powder
Solvent
Long-Acting Growth Hormone(LAGH) Segment by Application
Prader Willi Syndrome
SHOX Deficiency
Chronic Renal Insufficiency
Growth Hormone Deficiency (GHD)
Turner Syndrome
Small for Gestational Age(SGA)
Others
Long-Acting Growth Hormone(LAGH) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Acting Growth Hormone(LAGH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Long-Acting Growth Hormone(LAGH) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Acting Growth Hormone(LAGH).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Long-Acting Growth Hormone(LAGH) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Long-Acting Growth Hormone(LAGH) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Long-Acting Growth Hormone(LAGH) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Solvent
Applications
- Prader Willi Syndrome
- SHOX Deficiency
- Chronic Renal Insufficiency
- Growth Hormone Deficiency (GHD)
- Turner Syndrome
- Small for Gestational Age(SGA)
- Others
Companies covered
- Eli Lilly
- GeneScience Pharmaceuticals
- Pfizer
- Anhui Anke Biotechnology
- Sandoz International
- Novo Nordisk
- Merck Serono
- LG Life Sciences
- Ipsen
- Ferring Pharmaceuticals
- F. Hoffmann-La Roche
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Long-Acting Growth Hormone(LAGH) Market Size (2021-2032)
- 2.2.2 Global Long-Acting Growth Hormone(LAGH) Sales (2021-2032)
- 2.2.3 Global Long-Acting Growth Hormone(LAGH) Market Average Price (2021-2032)
- 2.3 Long-Acting Growth Hormone(LAGH) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Powder
- 2.3.3 Solvent
- 2.4 Long-Acting Growth Hormone(LAGH) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Prader Willi Syndrome
- 2.4.3 SHOX Deficiency
- 2.4.4 Chronic Renal Insufficiency
- 2.4.5 Growth Hormone Deficiency (GHD)
- 2.4.6 Turner Syndrome
- 2.4.7 Small for Gestational Age(SGA)
- 2.4.8 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Long-Acting Growth Hormone(LAGH) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Long-Acting Growth Hormone(LAGH) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Long-Acting Growth Hormone(LAGH) Revenue of Manufacturers (2021-2026)
- 3.4 Global Long-Acting Growth Hormone(LAGH) Average Price by Manufacturers (2021-2026)
- 3.5 Global Long-Acting Growth Hormone(LAGH) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Long-Acting Growth Hormone(LAGH), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Long-Acting Growth Hormone(LAGH), Product Type & Application
- 3.8 Global Manufacturers of Long-Acting Growth Hormone(LAGH), Established Date
- 3.9 Global Long-Acting Growth Hormone(LAGH) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eli Lilly
- 4.1.1 Eli Lilly Company Information
- 4.1.2 Eli Lilly Business Overview
- 4.1.3 Eli Lilly Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eli Lilly Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.1.5 Eli Lilly Recent Developments
- 4.2 GeneScience Pharmaceuticals
- 4.2.1 GeneScience Pharmaceuticals Company Information
- 4.2.2 GeneScience Pharmaceuticals Business Overview
- 4.2.3 GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.2.5 GeneScience Pharmaceuticals Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Anhui Anke Biotechnology
- 4.4.1 Anhui Anke Biotechnology Company Information
- 4.4.2 Anhui Anke Biotechnology Business Overview
- 4.4.3 Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.4.5 Anhui Anke Biotechnology Recent Developments
- 4.5 Sandoz International
- 4.5.1 Sandoz International Company Information
- 4.5.2 Sandoz International Business Overview
- 4.5.3 Sandoz International Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sandoz International Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.5.5 Sandoz International Recent Developments
- 4.6 Novo Nordisk
- 4.6.1 Novo Nordisk Company Information
- 4.6.2 Novo Nordisk Business Overview
- 4.6.3 Novo Nordisk Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Novo Nordisk Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.6.5 Novo Nordisk Recent Developments
- 4.7 Merck Serono
- 4.7.1 Merck Serono Company Information
- 4.7.2 Merck Serono Business Overview
- 4.7.3 Merck Serono Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Serono Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.7.5 Merck Serono Recent Developments
- 4.8 LG Life Sciences
- 4.8.1 LG Life Sciences Company Information
- 4.8.2 LG Life Sciences Business Overview
- 4.8.3 LG Life Sciences Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 LG Life Sciences Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.8.5 LG Life Sciences Recent Developments
- 4.9 Ipsen
- 4.9.1 Ipsen Company Information
- 4.9.2 Ipsen Business Overview
- 4.9.3 Ipsen Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ipsen Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.9.5 Ipsen Recent Developments
- 4.10 Ferring Pharmaceuticals
- 4.10.1 Ferring Pharmaceuticals Company Information
- 4.10.2 Ferring Pharmaceuticals Business Overview
- 4.10.3 Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.10.5 Ferring Pharmaceuticals Recent Developments
- 4.11 F. Hoffmann-La Roche
- 4.11.1 F. Hoffmann-La Roche Company Information
- 4.11.2 F. Hoffmann-La Roche Business Overview
- 4.11.3 F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Product Portfolio
- 4.11.5 F. Hoffmann-La Roche Recent Developments
5 Global Long-Acting Growth Hormone(LAGH) Market Scenario by Region
- 5.1 Global Long-Acting Growth Hormone(LAGH) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Long-Acting Growth Hormone(LAGH) Sales by Region: 2021-2032
- 5.2.1 Global Long-Acting Growth Hormone(LAGH) Sales by Region: 2021-2026
- 5.2.2 Global Long-Acting Growth Hormone(LAGH) Sales by Region: 2027-2032
- 5.3 Global Long-Acting Growth Hormone(LAGH) Revenue by Region: 2021-2032
- 5.3.1 Global Long-Acting Growth Hormone(LAGH) Revenue by Region: 2021-2026
- 5.3.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Region: 2027-2032
- 5.4 North America Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Country
- 5.4.1 North America Long-Acting Growth Hormone(LAGH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2032)
- 5.4.3 North America Long-Acting Growth Hormone(LAGH) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Country
- 5.5.1 Europe Long-Acting Growth Hormone(LAGH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2032)
- 5.5.3 Europe Long-Acting Growth Hormone(LAGH) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Long-Acting Growth Hormone(LAGH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Long-Acting Growth Hormone(LAGH) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Country
- 5.7.1 South America Long-Acting Growth Hormone(LAGH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2032)
- 5.7.3 South America Long-Acting Growth Hormone(LAGH) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Long-Acting Growth Hormone(LAGH) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Long-Acting Growth Hormone(LAGH) Sales by Type (2021-2032)
- 6.1.1 Global Long-Acting Growth Hormone(LAGH) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Type (2021-2032)
- 6.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Type (2021-2032)
- 6.2.1 Global Long-Acting Growth Hormone(LAGH) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Type (2021-2032)
- 6.3 Global Long-Acting Growth Hormone(LAGH) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Long-Acting Growth Hormone(LAGH) Sales by Application (2021-2032)
- 7.1.1 Global Long-Acting Growth Hormone(LAGH) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Application (2021-2032)
- 7.2 Global Long-Acting Growth Hormone(LAGH) Revenue by Application (2021-2032)
- 7.2.1 Global Long-Acting Growth Hormone(LAGH) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Application (2021-2032)
- 7.3 Global Long-Acting Growth Hormone(LAGH) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Long-Acting Growth Hormone(LAGH) Value Chain Analysis
- 8.1.1 Long-Acting Growth Hormone(LAGH) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Long-Acting Growth Hormone(LAGH) Production Mode & Process
- 8.2 Long-Acting Growth Hormone(LAGH) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Long-Acting Growth Hormone(LAGH) Distributors
- 8.2.3 Long-Acting Growth Hormone(LAGH) Customers
9 Global Long-Acting Growth Hormone(LAGH) Analyzing Market Dynamics
- 9.1 Long-Acting Growth Hormone(LAGH) Industry Trends
- 9.2 Long-Acting Growth Hormone(LAGH) Industry Drivers
- 9.3 Long-Acting Growth Hormone(LAGH) Industry Opportunities and Challenges
- 9.4 Long-Acting Growth Hormone(LAGH) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst